Beyond NFκB inhibition, bortezomib also induces the intracellular unfolded protein response (UPR) [11] and stabilizes the expression of the proapoptotic genes p53 [12], Bim [13], or noxa [14], indirectly contributing to bortezomib anti-tumor activity. Here, NFKB1 is linked to neoplasm.